Cancer Therapy News and Research

RSS

Altered flu virus could help combat pancreatic cancer, study finds

Researchers at Queen Mary University of London have developed a mechanism by which an altered or modified flu virus inhibit the growth of pancreatic cancer cells.

29 Jan 2018

Study sheds light on key protein involved in memory formation and brain growth

Ask a nonscientist what memories are made of and you'll likely conjure images of childhood birthday parties or wedding days. Charles Hoeffer thinks about proteins.

27 Jan 2018

Hitachi gets FDA clearance for commercialization of Real Time Image Gating System for Proton Beam Therapy Systems

Hitachi, Ltd. and Hokkaido University announced that it has obtained U.S. Food & Drug Administration 510(k) clearance on December 26, 2017 for the commercialization of "Real Time Image Gating System for Proton Beam Therapy Systems", allowing for its systems in the United States to treat patients with cutting-edge motion management together with its advanced Spot Scanning irradiation technology.

25 Jan 2018

Research could explain link between high-cholesterol diet and increased colon cancer risk

New UCLA research could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer.

25 Jan 2018

Artificial sweetener could lead to development of cancer therapies with less side effects

Artificial sweeteners are used in diet drinks and foods but also could someday be used as treatments targeting carbonic anhydrase IX (CA IX), a protein associated with aggressive cancers.

24 Jan 2018

Fluorescence imaging can track vitamin C in the body

Vitamin C is best known as a nutrient. In high enough doses, however, vitamin C also shows potential against many cancers, according to recent studies. To successfully develop vitamin C (chemically named ascorbic acid) as a medication, it is crucial to probe its concentration in the body, thus ensuring safe and effective doses.

24 Jan 2018

New gel offers protection for organs at risk during prostate cancer treatment

Radiation therapy is a popular and effective treatment for many men with prostate cancer, and now a temporary gel offers greater protection for organs at risk during treatments.

23 Jan 2018

Metabolic shift can result in congestive heart failure

The heart derives its energy primarily from fatty acids. However, if a metabolic shift to other energy sources takes place, this can result in congestive heart failure, scientists from the German Cancer Research Center and Heidelberg University Hospital have now discovered.

23 Jan 2018

Exercise could extend the life expectancy of breast cancer survivors, study states

New research conducted by a group of scientists at the University of Southern California (USC), whose findings are published in the Journal of Clinical Oncology, suggests that regular exercise could extend the life expectancy of breast cancer survivors, by lowering their increased risk of type 2 diabetes, heart disease, and potentially breast cancer recurrence.

23 Jan 2018

Researchers show association between microbiome and cancer-related blood infections

Cancer patients receive essential medicines, fluids, blood and nutrients through long, flexible tubes called central venous catheters, or central lines.

22 Jan 2018

Chinese researchers develop multifunctional vehicle to transport gene therapeutics

Gene editing is one of the hottest topics in cancer research. A Chinese research team has now developed a gold-nanoparticle-based multifunctional vehicle to transport the "gene scissors" to the tumor cell genome.

22 Jan 2018

Depressive symptoms associated with poorer survival in patients with head and neck cancer

In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival.

22 Jan 2018

Expert discusses how to stay healthy during flu season

This year's influenza outbreak is already the most widespread on record since health officials began keeping track about a dozen years ago, with millions of Americans being infected by emerging and current strains such as the dominant H3N2.

18 Jan 2018

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson Cancer Center report in Lancet Oncology.

18 Jan 2018

Study to test new precision medicine approach for metastatic pancreatic cancer

The Lustgarten Foundation has awarded Columbia University's Herbert Irving Comprehensive Cancer Center a three-year grant, as part of its Translational Clinical Program, to test a new precision medicine approach to the treatment of metastatic pancreatic cancer.

18 Jan 2018

Findings reveal conventional cancer therapy as double-edged sword

Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

18 Jan 2018

EXD2 enzyme facilitates protein production in mitochondria

Researchers from the Genomic Instability and Cancer Laboratory at Institute for Research in Biomedicine (IRB Barcelona) have identified a key role for EXD2 in protein production in the mitochondria, the cellular organelles responsible for the majority of energy generation.

17 Jan 2018

In Wisconsin, hopes rise for production of a lifesaving radioactive isotope

In a cornfield here, past the shuttered General Motors plant and the Janesville Terrace trailer home park, a facility not seen in the United States in three decades could soon rise: a manufacturing plant that will make a vital radioactive isotope used to detect cancer and other potentially fatal maladies in millions of people every year.

16 Jan 2018

Penn scientists identify new therapeutic target for treatment of melanoma

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma.

16 Jan 2018

Researchers develop remote-controlled mechanogenetics system to target and kill cancer cells

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

15 Jan 2018

Cancer Therapy News and Research

Altered flu virus could help combat pancreatic cancer, study finds

Study sheds light on key protein involved in memory formation and brain growth

Hitachi gets FDA clearance for commercialization of Real Time Image Gating System for Proton Beam Therapy Systems

Research could explain link between high-cholesterol diet and increased colon cancer risk

Artificial sweetener could lead to development of cancer therapies with less side effects

Fluorescence imaging can track vitamin C in the body

New gel offers protection for organs at risk during prostate cancer treatment

Metabolic shift can result in congestive heart failure

Exercise could extend the life expectancy of breast cancer survivors, study states

Researchers show association between microbiome and cancer-related blood infections

Chinese researchers develop multifunctional vehicle to transport gene therapeutics

Depressive symptoms associated with poorer survival in patients with head and neck cancer

Expert discusses how to stay healthy during flu season

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Study to test new precision medicine approach for metastatic pancreatic cancer

Findings reveal conventional cancer therapy as double-edged sword

EXD2 enzyme facilitates protein production in mitochondria

In Wisconsin, hopes rise for production of a lifesaving radioactive isotope

Penn scientists identify new therapeutic target for treatment of melanoma

Researchers develop remote-controlled mechanogenetics system to target and kill cancer cells

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News